A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)
A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)
复制标题
DOI:
10.1093/jjco/hyl128
复制
发表时间:
2007-01-01
影响因子:
2.4
通讯作者:
Nakagawa, Keiichi
中科院分区:
文献类型:
--
作者:
Nakamura, Naoki;Igaki, Hiroshi;Nakagawa, Keiichi
Objective: To evaluate the therapeutic effects of radiotherapy on spinal bone metastases from hepatocellular carcinoma (HCC).Methods: A retrospective review was conducted on 24 ambulatory patients with spinal bone metastases from HCC treated by radiotherapy from 1995 to 2004. Ambulatory rate and local progression-free rate after radiotherapy were analyzed. Eight (33%) of 24 patients had radiographic spinal cord compression from the spinal bone metastases before the treatment. Two (8.3%) of the 24 patients had some spinal deficits before the treatment. Biological equivalent dose (BED) with alpha/beta ratios of 10 ranged from 39 to 50.7 Gy (median 44.8 Gy).Results: The median observation period was 5.1 months ranging from 0.9 to 36.0 months. Among the 24 patients, five(21%) underwent salvage therapies, while of the remaining 19 patients four (21%) became nonambulatory by the last follow-up. The ambulatory rates at 3 months and 6 months were 85 and 63%, respectively. The local progression-free rates at 3 months and 6 months were 53 and 47%, respectively.Conclusions: Radiotherapy with a BED of 39-50.7 Gy (median 44.8 Gy) is not sufficiently effective for the patients with spinal bone metastases from HCC to prevent paralysis. Dose escalation with a highly precise radiation technique will need to be evaluated.